Jay Pepose - 13 Jun 2022 Form 4 Insider Report for Ocuphire Pharma, Inc. (IRD)

Role
Director
Signature
/s/ Emily J. Johns, by Power of Attorney
Issuer symbol
IRD
Transactions as of
13 Jun 2022
Net transactions value
$0
Form type
4
Filing time
15 Jun 2022, 16:01:30 UTC
Previous filing
13 Apr 2022
Next filing
06 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUP Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 13 Jun 2022 Common Stock 20,000 $1.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.